Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Risk of venous thromboembolism during treatment with antipsychotic agents.

Masopust J, Malý R, Vališ M.

Psychiatry Clin Neurosci. 2012 Dec;66(7):541-52. doi: 10.1111/pcn.12001. Review.

2.

Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management.

Jönsson AK, Spigset O, Hägg S.

CNS Drugs. 2012 Aug 1;26(8):649-62. doi: 10.2165/11633920-000000000-00000. Review.

PMID:
22731933
3.

[Specific treatments of the psychiatric community and thrombogenesis].

Khammassi N, Chrifi J, Hamza M, Cherif O.

Encephale. 2013 Apr;39(2):143-8. doi: 10.1016/j.encep.2012.06.007. Review. French.

PMID:
23095579
4.

Risk of venous thromboembolism due to antipsychotic drug therapy.

Hägg S, Jönsson AK, Spigset O.

Expert Opin Drug Saf. 2009 Sep;8(5):537-47. doi: 10.1517/14740330903117271. Review.

PMID:
19569978
5.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients..

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

6.

Antipsychotic-induced venous thromboembolism: a review of the evidence.

Hägg S, Spigset O.

CNS Drugs. 2002;16(11):765-76. Review.

PMID:
12383032
7.
8.

Evaluating the association between clozapine and venous thromboembolism.

Paciullo CA.

Am J Health Syst Pharm. 2008 Oct 1;65(19):1825-9. doi: 10.2146/ajhp070638. Review.

PMID:
18796423
9.

Antipsychotic drugs and venous thromboembolism.

Tromeur C, Couturaud F.

Thromb Res. 2012 Oct;130 Suppl 1:S29-31. doi: 10.1016/j.thromres.2012.08.267. Review.

PMID:
23026655
10.

[Venous thromboembolism as an adverse effect of antipsychotic treatment].

Bałkowiec-Iskra E, Cessak G, Kryńska Ł, Łoza B, Wojnar M.

Psychiatr Pol. 2014 Sep-Oct;48(5):997-1014. Review. Polish.

PMID:
25639019
11.

Thrombotic complications of treatment with antipsychotic drugs.

Shulman M, Jennifer Njoku I, Manu P.

Minerva Med. 2013 Apr;104(2):175-84. Review.

PMID:
23514994
12.

Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons.

Fraguas D, Correll CU, Merchán-Naranjo J, Rapado-Castro M, Parellada M, Moreno C, Arango C.

Eur Neuropsychopharmacol. 2011 Aug;21(8):621-45. doi: 10.1016/j.euroneuro.2010.07.002. Review.

PMID:
20702068
13.

Aripiprazole in schizophrenia and schizoaffective disorder: A review.

Stip E, Tourjman V.

Clin Ther. 2010;32 Suppl 1:S3-20. doi: 10.1016/j.clinthera.2010.01.021. Review.

PMID:
20152550
14.

[Management of venous thromboembolism in psychiatric patients].

Khammassi N, Haykel A, Cherif O.

Tunis Med. 2012 Jan;90(1):1-5. Review. French.

15.

[Prevention of venous thromboembolism in psychiatry].

Malý R, Masopust J, Konupcíková K.

Vnitr Lek. 2006 Mar;52 Suppl 1:73-8. Review. Czech.

PMID:
16637454
16.

Hyperglycemia and antipsychotic medications.

Haupt DW, Newcomer JW.

J Clin Psychiatry. 2001;62 Suppl 27:15-26; discussion 40-1. Review.

17.

Adverse effects of atypical antipsychotics : differential risk and clinical implications.

Haddad PM, Sharma SG.

CNS Drugs. 2007;21(11):911-36. Review.

PMID:
17927296
18.
19.

Tolerability profile of atypical antipsychotics in children and adolescents.

Stigler KA, Potenza MN, McDougle CJ.

Paediatr Drugs. 2001;3(12):927-42. Review.

PMID:
11772153
20.

Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents.

Maayan L, Correll CU.

J Child Adolesc Psychopharmacol. 2011 Dec;21(6):517-35. doi: 10.1089/cap.2011.0015. Review.

PMID:
22166172
Items per page

Supplemental Content

Support Center